Akums Drugs and Pharmaceutical (AKUMS) — Financial Flexibility Index
Akums Drugs and Pharmaceutical (AKUMS) has a Financial Flexibility Index of 0.70x as of March 2025. Free cash flow of Rs7.38 Billion (operating CF Rs4.65 Billion minus capex Rs2.72 Billion) represents 1% of total liabilities (Rs10.50 Billion). Check Akums Drugs and Pharmaceutical asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akums Drugs and Pharmaceutical Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Akums Drugs and Pharmaceutical across 4 annual periods. See Akums Drugs and Pharmaceutical (AKUMS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year free cash flow to debt coverage for Akums Drugs and Pharmaceutical. For the full company profile including market capitalisation, see Akums Drugs and Pharmaceutical (AKUMS) total market value.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | Rs7.38 Billion | Rs4.65 Billion | Rs10.50 Billion | ▲ +142.6% |
| 2024 | 0.29x | Rs8.10 Billion | Rs4.98 Billion | Rs27.96 Billion | ▲ +45.7% |
| 2023 | 0.20x | Rs5.05 Billion | Rs1.77 Billion | Rs25.43 Billion | ▲ +67.8% |
| 2022 | 0.12x | Rs2.89 Billion | Rs318.54 Million | Rs24.44 Billion | — |